DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,631,864 | -73.0% | 321,467 | -61.4% | 0.04% | -71.8% |
Q2 2023 | $24,561,084 | +91.0% | 832,297 | +49.1% | 0.15% | +86.2% |
Q1 2023 | $12,860,168 | +2.5% | 558,167 | +23.8% | 0.08% | -4.8% |
Q4 2022 | $12,540,920 | +13.7% | 450,950 | +25.4% | 0.08% | +9.1% |
Q3 2022 | $11,032,000 | +9.7% | 359,473 | +5.2% | 0.08% | +20.3% |
Q2 2022 | $10,055,000 | +31.6% | 341,674 | +43.9% | 0.06% | +68.4% |
Q1 2022 | $7,638,000 | -1.7% | 237,423 | +36.3% | 0.04% | +18.8% |
Q4 2021 | $7,771,000 | -11.7% | 174,242 | -0.2% | 0.03% | -11.1% |
Q3 2021 | $8,805,000 | -79.1% | 174,528 | -67.5% | 0.04% | -78.9% |
Q2 2021 | $42,142,000 | +54.3% | 537,246 | +12.3% | 0.17% | +39.0% |
Q1 2021 | $27,319,000 | -32.2% | 478,442 | -0.6% | 0.12% | -37.9% |
Q4 2020 | $40,312,000 | -15.7% | 481,284 | -64.0% | 0.20% | -34.9% |
Q3 2020 | $47,840,000 | +64.4% | 1,335,185 | +11.0% | 0.30% | +44.1% |
Q2 2020 | $29,098,000 | +45.7% | 1,203,410 | +5.5% | 0.21% | +1.4% |
Q1 2020 | $19,966,000 | +8.5% | 1,140,257 | +7.9% | 0.21% | +37.7% |
Q4 2019 | $18,410,000 | +22.9% | 1,056,846 | +8.1% | 0.15% | +5.6% |
Q3 2019 | $14,978,000 | -27.6% | 977,661 | -1.9% | 0.14% | -28.9% |
Q2 2019 | $20,680,000 | +8.5% | 996,147 | +21.3% | 0.20% | -3.4% |
Q1 2019 | $19,061,000 | +1925.6% | 820,904 | +1702.4% | 0.21% | +1500.0% |
Q4 2018 | $941,000 | -27.0% | 45,546 | -23.2% | 0.01% | -13.3% |
Q3 2018 | $1,289,000 | +171.4% | 59,269 | +90.4% | 0.02% | +150.0% |
Q2 2018 | $475,000 | -22.5% | 31,131 | 0.0% | 0.01% | -25.0% |
Q1 2018 | $613,000 | +25.9% | 31,131 | 0.0% | 0.01% | +33.3% |
Q4 2017 | $487,000 | – | 31,131 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |